RVPH Relative Valuation
RVPH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, RVPH is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
49.70
P/B
Median3y
5.83
Median5y
4.66
-82.25
FCF Yield
Median3y
-48.45
Median5y
-35.92
Competitors Valuation Multiple
The average P/S ratio for RVPH's competitors is 7.55, providing a benchmark for relative valuation. Reviva Pharmaceuticals Holdings, Inc. Corp (RVPH) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
NOVA
Sunnova Energy International Inc
0.180
USD
-8.16%
AMCX
AMC Networks Inc
6.250
USD
-0.79%
DIN
Dine Brands Global Inc
20.490
USD
+0.05%
GNTY
Guaranty Bancshares Inc
39.770
USD
+1.35%
EHAB
Enhabit Inc
8.050
USD
+2.55%
KMDA
Kamada Ltd
6.660
USD
+1.37%
QSI
Quantum-Si Inc
1.260
USD
+8.62%
CELC
Celcuity Inc
10.900
USD
+0.93%
KALV
Kalvista Pharmaceuticals Inc
13.550
USD
-0.37%
OTLY
Oatly Group AB (publ)
10.740
USD
-4.36%
FAQ
Is Reviva Pharmaceuticals Holdings, Inc. (RVPH) currently overvalued or undervalued?
Reviva Pharmaceuticals Holdings, Inc. (RVPH) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Reviva Pharmaceuticals Holdings, Inc. (RVPH) is between to according to relative valuation methord.
What is Reviva Pharmaceuticals Holdings, Inc. (RVPH) fair value?
How does RVPH's valuation metrics compare to the industry average?
What is the current P/B ratio for Reviva Pharmaceuticals Holdings, Inc. (RVPH) as of May 04 2025?
What is the current FCF Yield for Reviva Pharmaceuticals Holdings, Inc. (RVPH) as of May 04 2025?
What is the current Forward P/E ratio for Reviva Pharmaceuticals Holdings, Inc. (RVPH) as of May 04 2025?